CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+36.31%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$890M
AUM Growth
+$890M
(+35%)
Cap. Flow
+$90.2M
Cap. Flow
% of AUM
10.14%
Top 10 Holdings %
Top 10 Hldgs %
74.13%
Holding
34
New
2
Increased
15
Reduced
2
Closed
8
Top Buys
| 1 |
Vera Therapeutics
VERA
|
$42.1M |
| 2 |
Akero Therapeutics
AKRO
|
$41.3M |
| 3 |
Vaxcyte
PCVX
|
$40.7M |
| 4 |
Merus
MRUS
|
$27.6M |
| 5 |
IDEAYA Biosciences
IDYA
|
$18.2M |
Top Sells
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$47.4M |
| 2 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$26.8M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$13.6M |
| 4 |
Immunovant
IMVT
|
$10.3M |
| 5 |
Avidity Biosciences
RNA
|
$9.07M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBVT
26
DBV Technologies
DBVT
$264M
| $176K | 0.02% |
92,687
| – | – |
|
27
Acumen Pharmaceuticals
ABOS
$82.4M
| – | – |
-400,000
| Closed | -$1.62M |
|
28
Aclaris Therapeutics
ACRS
$209M
| – | – |
-635,000
| Closed | -$5.14M |
|
|
ALLK
29
DELISTED
Allakos
ALLK
| – | – |
-1,900,000
| Closed | -$8.46M |
|
30
Enanta Pharmaceuticals
ENTA
$180M
| – | – |
-217,253
| Closed | -$8.79M |
|
|
31
Avidity Biosciences
RNA
$5.99B
| – | – |
-590,705
| Closed | -$9.07M |
|
32
Rezolute
RZLT
$619M
| – | – |
-898,267
| Closed | -$1.72M |
|
|
BLU
33
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-6,579,359
| Closed | -$47.4M |
|
|
RXDX
34
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-127,156
| Closed | -$13.6M |
|